Now we're calling for national services to detect and treat type 1 early, with fair access to all.
Help us get there by supporting our Type 1 Tipping Point campaign & spreading the word about @elsadiabetes study.
Learn more about this historic milestone: https://t.co/17Y7LyMEj1
We're tipping into a new era for type 1 diabetes.
For the first time, a treatment to slow down the development of type 1 in its early stages will be available on the NHS.
Today's decision from NICE means NHS England has 90 days to put services in place to deliver teplizumab.
We spoke with Gary, one of the trial participants, about his experience, why he got involved and why he believes research is the way forward. (2/2)
➡️ Find out more: https://t.co/99xCDiirjP
The first in-human trial from the #Type1DiabetesGrandChallenge is well under way.
And it's exploring whether two existing drugs can protect the insulin-producing beta cells in type 1 diabetes 🔬(1/2)
These findings suggest pharmacy‑based testing could support earlier diagnosis and expand access to diabetes prevention - particularly for people in more deprived communities who may be at higher risk and missing out on care. (3/3)
New paper in @DiabeticMed highlights that community pharmacies using on‑the‑spot blood tests could help identify undiagnosed type 2 diabetes - and reach people in more deprived communities who may be missing out on diagnosis and prevention. 📊 (1/3)
https://t.co/5AUmhMsweq
Of 500 people tested in pharmacies, 15% had prediabetes and 4% likely undiagnosed type 2 diabetes, highlighting significant hidden risk. Around half joined a prevention programme - double GP referral rates - with pharmacies also reaching younger and more deprived groups. (2/3)
Will your MP be in the room? 🤔
Next month we’re bringing our new campaign, Type 1 Tipping Point, to parliament. We’ll be celebrating the incredible progress made in diabetes research, while making the case for what comes next. (1/4)
As MPs are more likely to attend when they hear from their constituents, we need your help.
Let them know you want them in the room to hear first-hand how research must become a reality and reach the people who need it.
➡️ Invite your MP: https://t.co/TxrSPv71oI
(3/4)
You can sign up to this study until the end of June. The researchers are looking for young people living with type 1 & ADHD, their parents, and healthcare professionals.
Researchers at Cardiff University are recruiting young people aged 11-18 living with type 1 diabetes and ADHD, their parents, and healthcare professionals to their study exploring the psychological support needs of this group.
Researchers at the University of Birmingham are recruiting people living with type 1 diabetes, or parents/guardians of children under 16 with type 1, to a study exploring views on potential type 1 treatments.
Researchers at King’s College London are recruiting people living with diabetes to a study exploring experiences of feeling dismissed by healthcare services.
Participation involves completing some online questionnaires.
We’re at the Type 1 Diabetes Early Detection Summit at @unibirmingham, hearing about the incredible pace of progress in the field.
@DrLucyChambers talking on @DiabetesUK’s work to raise awareness of early-stage type 1, screening, immunotherapy & to galvanise the community.
The findings make clear that reducing stigma should not fall on people with the condition alone and the need for greater awareness among HCPs and the public to #StrikeOutStigma.
Along with targeted support to reduce stigma and improve wellbeing.
#diabetesweek (3/3)
New findings in @DiabeticMed from @DiabetesUK funded research show stigma is a widespread and significant part of life for people with type 1 diabetes, with 96% surveyed reporting at least one experience of being judged, blamed or misunderstood. (1/3)
🔗https://t.co/RQamuXENVO
Survey findings show that stigma is most common among younger adults, women, people with higher BMI, insulin pump users, and those experiencing anxiety or depression - highlighting its strong link with mental wellbeing. (2/3)